Understanding the Regulatory Landscape for Diagnostic Tests

RU Okay? Understanding the Regulatory Landscape for Diagnostic Tests in the US, UK and EU

Overview


Join us for an informative discussion on the evolving landscape of In Vitro Diagnostics (IVD) and Lab Developed Tests (LDTs). Our panel of industry leaders will delve into the latest developments from across the US, UK and Europe.

REGISTER

3:00 – 4:00 pm (GMT)
4:00 – 5:00 pm (CET)
10:00 – 11:00 am (EST)

Complimentary Webinar

Agenda


  • The FDA’s proposed rule on LDTs issued in September 2023 – what will this mean for test providers and manufacturers?
  • The landscape for Research Use Only and LDTs in the US, UK and Europe – what are the current exemptions?
  • EU IVDR timelines and extensions – the current transition and understanding when a change is significant
  • Compliance with the new standards – what do you need to know about clinical evidence and timelines to certification?
  • The UK IVD current landscape and the timelines for proposed new regulations – what flexibility is there?

Dig Deeper

Nashville, TN / McDermott Event / May 6-9, 2025

McDermott HealthEx

Paris, France / McDermott Event / April 2, 2025

European Health & Life Sciences Symposium 2025

Miami, FL / McDermott Event / March 5-6, 2025

HPE Miami 2025

San Francisco, CA / McDermott Event / January 14, 2025

McDermott Forum During the 2025 J.P. Morgan Healthcare Conference

London / McDermott Event / January 14, 2025

McDermott Private Capital and Restructuring Academy